Power Law company profile

MedReleaf

Biotech & Life Sciences · Ontario, United States · Founded 2014 Unicorn

A Canadian Licensed Producer and distributor of medical cannabis

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Global footprint

Where MedReleaf has talent and traffic

Workforce by country

4 countries with
team presence

🇨🇦 Canada58.9%

🇦🇺 Australia27.8%

🇮🇳 India9.6%

🇨🇳 China8.9%

4 countries shown

Patent intelligence

$106k patent portfolio · 5 active families

Estimated portfolio value

$106k

<0.01% of valuation · comparable to top peer Curaleaf ($103k)

5 active patent families

Where MedReleaf innovates Cannabis ruderalisCultivarMicrobiological growthCannabisCannabis substance

Where MedReleaf concentrates vs peers

Each axis is a top-10 topic across MedReleaf and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about MedReleaf

An AI-synthesized read of the highest-engagement posts about MedReleaf on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See MedReleaf on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles